Status:
COMPLETED
The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Stroke
Transient Ischemic Attack
Eligibility:
All Genders
Brief Summary
Sodium imbalance is common and an adverse prognostic factor in hospitalized patients. However, identifying the causes of sodium imbalance is challenging in clinical practice. Levels of antidiuretic ho...
Detailed Description
Background: Sodium imbalance is common and an adverse prognostic factor in hospitalized patients. However, identifying the causes of sodium imbalance is challenging in clinical practice. Levels of an...
Eligibility Criteria
Inclusion
- All consecutive patients who are admitted to the emergency department with an ischemic or hemorrhagic stroke or transient ischemic attach (TIA) according to the World Health organization criteria \[37\] with symptom onset within the last 3 days.
- All consecutive patients who undergo intracranial surgery due to
- pituitary tumors
- intracerebral hemorrhage (ICH)
- subarachnoidal hemorrhage (SAH)
- chronic subdural hematoma
- head trauma with contusion cerebri
- intracranial abcesses
Exclusion
- Patients without informed consent.
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
469 Patients enrolled
Trial Details
Trial ID
NCT00390962
Start Date
November 1 2006
End Date
March 1 2008
Last Update
September 23 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Canton of Basel-City, Switzerland, 4051